Clinical reappraisal of the Composite International Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) by Kessler, Ronald et al.
Clinical reappraisal of the Composite
International Diagnostic Interview
Screening Scales (CIDI-SC) in the Army
Study to Assess Risk and Resilience
in Servicemembers (Army STARRS)
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Kessler, Ronald C., Patcho N. Santiago, Lisa J. Colpe, Catherine L.
Dempsey, Michael B. First, Steven G. Heeringa, Murray B. Stein,
et al. 2013. “Clinical Reappraisal of the Composite International
Diagnostic Interview Screening Scales (CIDI-SC) in the Army Study
to Assess Risk and Resilience in Servicemembers (Army STARRS).”
International Journal of Methods in Psychiatric Research 22 (4)
(December): 303–321. doi:10.1002/mpr.1398.
Published Version doi:10.1002/mpr.1398
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33459441
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Open Access Policy Articles, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#OAP
Clinical reappraisal of the Composite International Diagnostic
Interview Screening Scales (CIDI-SC) in the Army Study to
Assess Risk and Resilience in Servicemembers (Army STARRS)
Ronald C. Kessler1, Patcho N. Santiago2, Lisa J. Colpe3, Catherine L. Dempsey2, Michael
B. First4, Steven G. Heeringa5, Murray B. Stein6, Carol S. Fullerton2, Michael J. Gruber1,
James A. Naifeh2, Matthew K. Nock7, Nancy A. Sampson1, Michael Schoenbaum3, Alan M.
Zaslavsky1, and Robert J. Ursano2 on behalf of the Army STARRS Collaborators
1Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
2Center for the Study of Traumatic Stress, Department of Psychiatry, Uniformed Services
University of the Health Sciences, Bethesda, Maryland, USA
3National Institute of Mental Health, Bethesda, Maryland, USA
4Department of Psychiatry, Columbia University, New York, New York and New York State
Psychiatric Institute, New York, New York, USA
5University of Michigan, Institute for Social Research, Ann Arbor, Michigan, USA
Correspondence: Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue,
Boston, MA 02115; kessler@hcp.med.harvard.edu; 617-432-3587 (voice); 617-432-3588 (fax).
Additional Contributions: The Army STARRS Team consists of Co-Principal Investigators: Robert J. Ursano, MD (Uniformed
Services University of the Health Sciences) and Murray B. Stein, MD, MPH (University of California San Diego and VA San Diego
Healthcare System); Site Principal Investigators: Steven Heeringa, PhD (University of Michigan) and Ronald C. Kessler, PhD
(Harvard Medical School); NIMH collaborating scientists: Lisa J. Colpe, PhD, MPH and Michael Schoenbaum, PhD; Army liaisons/
consultants: COL Steven Cersovsky, MD, MPH (USAPHC) and Kenneth Cox, MD, MPH (USAPHC). Other team members: Pablo A.
Aliaga, MA (Uniformed Services University of the Health Sciences); COL David M. Benedek, MD (Uniformed Services University
of the Health Sciences); Susan Borja, PhD (National Institute of Mental Health); Gregory G. Brown, PhD (University of California
San Diego); Laura Campbell-Sills, PhD (University of California San Diego); Catherine L. Dempsey, PhD, MPH (Uniformed Services
University of the Health Sciences); Richard Frank, PhD (Harvard Medical School); Carol S. Fullerton, PhD (Uniformed Services
University of the Health Sciences); Nancy Gebler, MA (University of Michigan); Joel Gelernter, MD (Yale University); Robert K.
Gifford, PhD (Uniformed Services University of the Health Sciences); Stephen E. Gilman, ScD (Harvard School of Public Health);
Marjan G. Holloway, PhD (Uniformed Services University of the Health Sciences); Paul E. Hurwitz, MPH (Uniformed Services
University of the Health Sciences); Sonia Jain, PhD (University of California San Diego); Tzu-Cheg Kao, PhD (Uniformed Services
University of the Health Sciences); Karestan C. Koenen, PhD (Columbia University); Lisa Lewandowski-Romps, PhD (University of
Michigan); Holly Herberman Mash, PhD (Uniformed Services University of the Health Sciences); James E. McCarroll, PhD, MPH
(Uniformed Services University of the Health Sciences); Katie A. McLaughlin, PhD (Harvard Medical School); James A. Naifeh, PhD
(Uniformed Services University of the Health Sciences); Matthew K. Nock, PhD (Harvard University); Rema Raman, PhD
(University of California San Diego); Nancy A. Sampson, BA (Harvard Medical School); LCDR Patcho N. Santiago, MD, MPH
(Uniformed Services University of the Health Sciences); Michaelle Scanlon, MBA (National Institute of Mental Health); Jordan
Smoller, MD, ScD (Harvard Medical School); Nadia Solovieff, PhD (Harvard Medical School); Michael L. Thomas, PhD (University
of California San Diego); Christina Wassel, PhD (University of Pittsburgh); and Alan M. Zaslavsky, PhD (Harvard Medical School).
Declaration of interest statement: In the past five years Kessler has been a consultant for Eli Lilly & Company, Glaxo, Inc.,
Integrated Benefits Institute, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc., Sanofi-Aventis Groupe, Shire US Inc., and
Transcept Pharmaceuticals Inc. and has served on advisory boards for Johnson & Johnson. Kessler has had research support for his
epidemiological studies over this time period from Eli Lilly & Company, EPI-Q, GlaxoSmithKline, Ortho-McNeil Janssen Scientific
Affairs, Sanofi-Aventis Groupe, Shire US, Inc., and Walgreens Co. Kessler owns a 25% share in DataStat, Inc. First received
consultation fees from the Henry M. Jackson Foundation for the Advancement of Military Medicine, the sponsor of the study. Stein
has in the last three years been a consultant for Healthcare Management Technologies and had research support for pharmacological
imaging studies from Janssen. The remaining authors report nothing to disclose.
NIH Public Access
Author Manuscript
Int J Methods Psychiatr Res. Author manuscript; available in PMC 2014 December 01.
Published in final edited form as:
Int J Methods Psychiatr Res. 2013 December ; 22(4): 303–321. doi:10.1002/mpr.1398.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
6Departments of Psychiatry and Family and Preventive Medicine, University of California San
Diego, La Jolla, California and VA San Diego Healthcare System, San Diego, California, USA
7Department of Psychology, Harvard University, Cambridge, Massachusetts, USA
Abstract
A clinical reappraisal study was carried out in conjunction with the Army STARRS All-Army
Study (AAS) to evaluate concordance of DSM-IV diagnoses based on the Composite International
Diagnostic Interview screening scales (CIDI-SC) and PTSD Checklist (PCL) with diagnoses based
on independent clinical reappraisal interviews (Structured Clinical Interview for DSM-IV
[SCID]). Diagnoses included: lifetime mania/hypomania, panic disorder, and intermittent
explosive disorder; 6-month adult attention-deficit/hyperactivity disorder; and 30-day major
depressive episode, generalized anxiety disorder, PTSD, and substance (alcohol or drug) use
disorder (abuse or dependence). The sample (n=460) was weighted for over-sampling CIDI-
SC/PCL screened positives. Diagnostic thresholds were set to equalize false positives and false
negatives. Good individual-level concordance was found between CIDI-SC/PCL and SCID
diagnoses at these thresholds (AUC = .69–.79). AUC was considerably higher for continuous than
dichotomous screening scale scores (AUC = .80–.90), arguing for substantive analyses using not
only dichotomous case designations but also continuous measures of predicted probabilities of
clinical diagnoses.
Keywords
Composite International Diagnostic Interview (CIDI); CIDI Screening Scales (CIDI-SC);
diagnostic concordance; PTSD Checklist (PCL); screening scales; validity
As described in more detail earlier in this issue (Kessler et al., this issue) and elsewhere
(Ursano et al., under review), the Army Study to Assess Risk and Resilience in
Servicemembers (Army STARRS; www.armystarrs.org) is a multi-component
epidemiological and neurobiological study of risk and resilience factors for suicidality and
its psychopathological correlates in the U.S. Army. The literature on risk and resilience
factors for suicidality makes it clear that mental disorders are powerful risk factors (Nock et
al., 2008; Nock et al., in press). As a result, a wide range of mental disorders were assessed
in the Army STARRS surveys. However, due to the size and logistical complexities of these
surveys, which are described earlier in this issue (Heeringa et al., this issue), it was
impossible to administer an in-depth psychiatric diagnostic interview to participants.
Instead, mental disorders were assessed with short self-administered screening scales.
A number of screening scales exist to assess such disorders as attention-deficit hyperactivity
disorder (Kessler et al., 2005a), bipolar disorder (Hirschfeld et al., 2000), generalized
anxiety disorder (Spitzer et al., 2006), major depressive episode (Kroenke et al., 2001), and
post-traumatic stress disorder (Breslau et al., 1999). Although in some cases these scales
were developed originally to assess symptom severity among patients in treatment, they
subsequently have been adapted for use either as web-based tools for self-diagnosis (Donker
et al., 2009; Farvolden et al., 2003) or as brief evaluations of mental disorders in primary
care settings or community surveys (Broadhead et al., 1995; Gaynes et al., 2010; Hunter et
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al., 2005; Kessler et al., 2012). Clinical reappraisal studies comparing scores on these
screening scales with independent clinical diagnoses show that many of these screening
scales have good concordance with clinical diagnoses (Kessler and Pennell, in press).
The screening scales that form the core diagnostic assessment in Army STARRS are the
WHO Composite International Diagnostic Interview Screening Scales (CIDI-SC) (Kessler et
al., 2012). These were selected largely because they are a coordinated set of short scales that
cover a wide range of disorders and have good psychometric properties. However, another
appeal of the CIDI-SC scales is that they are embedded in the WHO Composite
International Diagnostic Interview (CIDI) (Kessler and Üstün, 2004), the research diagnostic
interview used in most large-scale epidemiological surveys of psychiatric disorders
throughout the world (Haro et al., 2006). Use of the CIDI-SC scales in Army STARRS
thereby creates a crosswalk to an in-depth diagnostic interview that might be used in more
focused follow-up studies of Army STARRS high-risk subsamples. The exception is that we
used the Post-Traumatic Stress Disorder (PTSD) Checklist (PCL) (Weathers et al., 1993) to
assess PTSD based on the widespread use of this screening scale in previous military studies
of PTSD (Barnes et al., 2013; Brown et al., 2012; Jones et al., 2012) coupled with strong
evidence for the validity of the PCL in both military and civilian samples (Wilkins et al.,
2011).
Although good concordance of DSM-IV (American Psychiatric Association, 1994)
diagnoses based on the CIDI-SC (Kessler et al., 2005a; Kessler et al., 2007; Kessler et al.,
2006a; Kessler et al., 2012) and PCL (Wilkins et al., 2011) with diagnoses based on
independent clinical reappraisal interviews has been reported in a number of studies, this
does not guarantee that these screening scales will perform equally well among soldiers in
the Army STARRS surveys. As a result, a new clinical reappraisal study was carried out in
conjunction with the Army STARRS All-Army Study (AAS) (Ursano et al., under review)
to examine the psychometric characteristics of the CIDI-SC and PCL in the context of the
field conditions encountered in the Army STARRS surveys. Results of this clinical
reappraisal study are presented in the current report.
METHODS
The samples
The All-Army Study (AAS)—As described in more detail previously in this issue
(Kessler et al., this issue), the AAS is a cross-sectional survey of active duty Army
personnel exclusive of Soldiers in Basic Combat Training administered in quarterly
replicates to a total of nearly 50,000 Soldiers during calendar years 2011–2012. Each
quarterly AAS replicate consisted of a stratified (by Army Command-location and unit size)
probability sample of Army units, excluding units of fewer than 30 Soldiers (less than 2% of
all Army personnel). All targeted personnel in these units were ordered to attend an
informed consent presentation explaining study purposes, confidentiality procedures, and the
voluntary nature of participation before requesting written informed consent for a group
self-administered questionnaire (SAQ). Respondents were additionally asked for consent to
link their Army and Department of Defense administrative records to their SAQ responses
and to participate in future longitudinal follow-up data collections. Identifying information
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(name, birthday, SSN for record linkage; telephone number, email, secondary contact
information for longitudinal follow-up) was collected from consenting respondents and kept
in a separate secure file. These recruitment, consent, and data protection procedures were
approved by the Human Subjects Committees of the Uniformed Services University of the
Health Sciences for the Henry M. Jackson Foundation (the primary grantee), the Institute for
Social Research at the University of Michigan (the organization implementing Army
STARRS surveys), and all other collaborating organizations.
The clinical reappraisal study (CRS) was carried out between March 2012 and November
2012. All quarterly AAS replicates over that time period were based on representative
samples of Soldiers stationed both in the continental U.S. and elsewhere in the world other
than a combat theater, while the Q2-3 2012 replicates also included probability samples of
Soldiers stationed in Afghanistan who were surveyed in group-administered sessions while
they were passing through Kuwait either leaving for or returning from their mid-tour leave.
However, because of logistical issues requiring that the CRS clinical reappraisal interviews
be administered within two weeks of the AAS survey, the CRS was implemented
exclusively in the continental U.S. among Regular (active component) Army AAS
respondents providing consent for administrative data linkage and completing the SAQ.
Activated Army Reserve and National Guard respondents were excluded from the CRS due
to small numbers.
Although, as noted above, all unit members in these replicates were ordered to report to the
informed consent session, 19.4% of those in the replicates used for the CRS were absent due
to conflicting duty assignments. The vast majority of those attending (99.6%) consented to
the survey and 98.8 % of consenters completed the survey. In addition, 71.4% of completers
provided successful record linkage. Most incomplete surveys were due to logistical
complications (e.g., units either arriving late to survey sessions or having to leave early),
although some respondents needed more than the allotted 90 minutes to complete the
survey. The survey completion-successful-linkage cooperation rate was 63.9% and the
completion-successful-linkage response rate was 51.5 % based on the American Association
of Public Opinion Research COOP1 and RR1 calculation methods (American Association
for Public Opinion Research, 2009).
The clinical reappraisal study sample—In order to evaluate the concordance of
diagnoses based on the CIDI-SC and PCL in the AAS with independent clinical diagnoses, a
sample of AAS respondents was selected to participate in clinical follow-up interviews
within two weeks of completing the AAS in selected AAS sessions. As soon as the AAS
survey was completed in these sessions, each AAS respondent was classified as threshold,
subthreshold or no on each of the eight screening scales considered here. A probability
subsample of AAS respondents from the session was then invited to participate in a
confidential clinical reappraisal interview with the goal of obtaining a total (i.e., over the
entire 9-month interview recruitment period) of 30 CRS interviews with respondents
selected at random from those classified as threshold cases on each diagnosis, 10 from
among those classified as subthreshold on each diagnosis, and 40 respondents selected at
random from those classified as meeting neither threshold nor subthreshold criteria for any
diagnosis. CRS respondents with each diagnosis were selected with replacement (i.e., the
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same respondent could be selected for more than one diagnosis). The initial sampling
fractions varied across disorders due to differences in prevalence among the disorders. These
sampling fractions were then modified over sessions in order to achieve a roughly equal
distribution of cases within each diagnosis across sessions while meeting the sample quotas.
The 460 clinical interviews completed by the end of the CRS is more than the 360 needed
(i.e., 30 interviews with threshold CIDI-SC/PCL cases for each of eight disorders plus 10
interviews with CIDI-SC/PCL subthreshold cases for each of these disorders plus 40
respondents screening negative on all eight CIDI-SC/PCL scales) because it was necessary
to recruit additional respondents in the later replicates to fill the sample quotas for the least
common disorders.
Invitations to participate in the CRS were made through unit points-of-contact who
scheduled two-hour time blocks during which respondents were relieved of their usual duty
assignments in order to report to the Army STARRS study office on the installation. Once at
the study office, an Army STARRS data collection specialist explained the content and
purposes of the CRS and obtained written informed consent to participate. Consenting
respondents were then assigned to a private room where they were administered the CRS
interview telephonically by one of the CRS clinical interviewers, all of whom were located
at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda,
Maryland. The CRS clinical supervisor (CLD), also located at USUHS, coordinated with
Army STARRS data collection specialists at the local AAS installations to schedule these
remote CRS telephone interviewers.
An overview of screening scale content
Screening scales were included in the AAS for eight DSM-IV disorders that have been
found in previous general population studies to be significant predictors of suicidality (Nock
et al., 2008; Nock et al., in press; Nock et al., 2009). These include two mood disorders
(major depressive episode, mania/hypomania), three anxiety disorders (panic disorder with
or without agoraphobia, generalized anxiety disorder, PTSD), and three externalizing
disorders (adult attention-deficit hyperactivity disorder, intermittent explosive disorder,
substance use disorder).
Symptom questions in most CIDI-SC scales ask respondents about the frequency of
particular symptoms over the 30 days before interview using the response options all or
almost all of the time, most of the time, some of the time, a little of the time, and none of the
time. Each CIDI-SC scale has an embedded skip logic whereby all respondents are
administered one or more entry questions and then either skipped if they fail to endorse
these questions or continue to a series of follow-up questions if they endorse the entry
question(s). This approach was designed to reduce overall scale administration time and
respondent burden while minimizing the number of true positives incorrectly skipped out by
the entry questions. Respondents who fail to endorse any of the entry questions are asked a
total of 46 questions across all eight scales combined, while respondents who endorse every
single question are asked an additional 82 questions.
The CIDI-SC major depressive episode (MDE) scale begins with four entry questions that
ask about being sad, depressed, or discouraged; having little or no interest or pleasure in
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things; and feeling down on yourself, no good, or worthless (Kessler et al., 2012).
Respondents who report that at least one of these symptoms occurred at least some of the
time in the past 30 days are administered 10 additional questions to assess the inclusion
criteria of MDE. The some of the time threshold, while low for a DSM-IV diagnosis of MDE
(which requires depressive symptoms to last most of the day nearly every day for two weeks
or longer), was chosen because we wanted to collect information not only on threshold cases
but also on subthreshold manifestions of MDE. A similar attempt to collect information
about subthreshold symptoms was made in selecting stem question skip rules for each of the
other screening scales.
The CIDI-SC mania-hypomania (MHM) scale focuses on subthreshold hypomania as well
as mania and hypomania based on evidence that subthreshold hypomania can be highly
impairing (Merikangas et al., 2007). In addition, the questions focus on lifetime rather than
30-day prevalence due to the fact that recent bipolar disorder (BPD) can manifest as either
MHM or as MDE. As described in more detail elsewhere (Kessler et al., 2006a; Kessler et
al., 2012), the single MHM entry question begins with a vignette describing a hypomanic
episode and then asks respondents if they ever had an episode of this sort at any time in their
life. A positive response is followed by four questions about the frequency of core MHM
symptoms during a typical intense episode of this sort. These symptoms include being much
higher, happier, or optimistic than usual; much more irritable than usual; so hyper or
wound up that you felt out of control; and having thoughts race through your mind so fast
you could hardly keep track of them. Respondents who report that at least one of these
symptoms occurrs at least some of the time during a typical intense episode are then
administered six additional questions about the inclusion criteria of MHM and are then
asked about episode recency to assess 30-day prevalence of MHM. Lifetime rather than 30-
day MHM is evaluated here due to the rarity of 30-day MHM in the AAS sample.
The CIDI-SC panic disorder (PD) scale includes two entry questions about lifetime atacks of
panic, anxiety, or strong fear that came on very suddenly and made you feel very frightened
or uneasy; and attacks of heart pounding or chest pain that came on very suddenly and
made you feel very frightened or uneasy (Kessler et al., 2012). A positive response to either
entry question is followed by one additional question on how often these attacks are
triggered (i.e., occur in situations where the respondent has a strong fear – like a fear of
snakes or heights – or where the respondent is in real danger – like a car accident) versus
untriggered (i.e., occur without provocation “out of the blue”). Respondents who report ever
having untriggered attacks are then administered 13 additional questions to assess the
remaining DSM-IV inclusion criteria of PD. Lifetime rather than 30-day PD is evaluated
here due to the rarity of 30-day PD in the AAS sample.
The CIDI-SC generalized anxiety disorder (GAD) scale includes five entry questions about
30-day frequency of being anxious or nervous; worried about a number of different things;
more anxious or worried than other people in your same situation; worried about things
most other people don’t worry about; and having trouble controlling your worry or anxiety
(Kessler et al., 2012). Respondents who report any of these symptoms at least some of the
time are administered an additional nine questions to assess the remaining DSM-IV
inclusion criteria of GAD along with a final question to assess persistence of symptoms. As
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a minimum duration of six months is required to meet DSM-IV criteria of GAD, the CIDI-
SC assesses duration of symptoms, although the concordance data reported here are for
symptoms in the 30-days before interview.
As noted above, PTSD is assessed in the AAS with the PCL. The PCL Civilian version
(Weathers et al., 1993) was used in Army STARRS because we covered traumatic
experiences both in and out of the line of duty. This is a 17-question scale that assesses the
17 DSM-IV Criterion B-D symptoms of PTSD. Although there are no entry questions in the
PCL, AAS respondents are first asked 15 questions about traumatic experiences (TEs) that
might have happened to them during deployments and 15 additional questions about TEs
that might have happened at to them at any other time in life. Only respondents who report
at least one of these 30 TEs are administered the PCL. The PCL questions ask how much
respondents were bothered in the past 30 days by symptoms associated with any of the TEs
they ever experienced. Response categories are extremely, quite a bit, moderately, a little
bit, and not at all.
The CIDI-SC adult attention-deficit/hyperactivity disorder (ADHD) scale includes four
entry questions found in previous research to provide an optimal short inclusion screen for
ADHD in the adult general population (Kessler et al., 2010a). Respondents who report at
least two of these symptoms at least some of the time in the past six months then receive an
additional 8 questions shown in a number of previous studies to detect adult ADHD with
good accuracy (Kessler et al., 2007; Kessler et al., 2010a; Kessler et al., 2009).
The CIDI-SC intermittent explosive disorder (IED) scale includes one entry question about
lifetime attacks of anger when the respondent all of a sudden … lost control and either
broke or smashed something worth more than a few dollars, hit or tried to hurt someone, or
threatened someone (Kessler et al., 2006b). A positive response is followed by 6 additional
questions that assess the remaining DSM-IV inclusion criteria of IED. As the assessment of
IED followed the same logic as the assessment of PD, lifetime rather than 30-day IED is
evaluated here in parallel with the evaluation of PD.
The CIDI-SC assessment of substance use disorder (SUD), finally, begins with 12 entry
questions about quantity-frequency of alcohol use, illicit drug use, and prescription drug
misuse, where the latter is defined as use either without a doctor’s prescription, more than
prescribed, or to get high, buzzed, or numbed out. Prescription drug misuse is included in
the assessment based on evidence that it is considerably more common than illicit drug use
in the Army (Bray et al., 2010). Respondents who report any of these types of substance use
are then administered the four CIDI-SC questions about DSM-IV substance abuse in the 30
days before interview and eight additional questions to screen for substance dependence in
the 30 days before interview including five from the Severity of Dependence Scale (Gossop
et al., 1995) and three additional CIDI-SC questions. Substance use disorders (i.e., either
abuse or dependence) are assessed only once for alcohol and/or drugs combined.
Scoring the screening scales
Each screening scale was initially scored continuously by summing values across all items
in the scale, assigning respondents who were skipped out after screening questions the
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lowest possible scores on the remaining items. Receiver operating characteristic curve
(ROC) analysis (Margolis et al., 2002) was then used to estimate area under the ROC curve
(AUC) for the entire continuous scale and to dichotomize the scale at a point that optimized
aggregate concordance between the prevalence estimate based on the SCID and the
prevalence estimate based on the CIDI-SC at the designated threshold. This threshold also
makes the number of false positives equal the number of false negatives. It is noteworthy,
though, that other criteria exist to select diagnostic thresholds and that decisions about which
threshold to choose can vary depending on the criterion used. For example, if we had wanted
to use the screening scales in a primary care setting to select patients for more in-depth
evaluation, we might have lowered the threshold to the point where the vast majority of
SCID cases were detected. Or if we were using the screening scales to select patients for a
clinical intervention, we might have raised the threshold to the point where the vast majority
of screened positives consisted of SCID cases. If the relative importance of minimizing false
positives and minimizing false negatives can be specified based on the considerations of
such competing criteria, it is possible to minimize this weighted sum of errors in a formal
way (Kraemer, 1992). Based on these considerations, a number of alternative thresholds are
examined below.
The clinical reappraisal interview
The clinical reappraisal interview was a modified Research Version, Non-Patient Edition of
the Structured Clinical Interview for DSM-IV (SCID-I) (First et al., 2002) focused on the
eight syndromes under study with the variations in recall periods noted above to match the
recall periods used in the screening scales. As noted above, these interviews were
administered by telephone. Telephone administration is now widely accepted in clinical
reappraisal studies based on evidence of comparable validity to in-person administration
(Kendler et al., 1992; Rohde et al., 1997; Sobin et al., 1993). A great advantage of telephone
administration is that a centralized and closely supervised clinical interview staff can carry
out the interviews without the geographic restrictions required for face-to-face clinical
assessment. A disadvantage is that people without telephones cannot be included in the
assessment. As noted below, though, this difficulty was resolved in the Army STARRS CRS
by having pre-designated respondents report to the central Army STARRS research office
on their installations, where they were placed in a private room and interviewed remotely by
telephone.
A major impediment to making accurate evaluations of concordance between screening
scales and clinical diagnoses is the fact that respondents are inconsistent in their reports over
time. Indeed, our own previous experience and that of other researchers shows consistently
that respondents in community surveys tend to report less and less as they are interviewed
more and more due to respondent fatigue (Bromet et al., 1986). Part of this pattern is a
tendency for respondents to endorse a smaller number of diagnostic stem questions in
follow-up interviews than in initial interviews (Kessler et al., 1998), leading to the biased
perception that initial fully-structured assessments overestimate prevalence compared to
clinical reappraisal interviews. Consistent with the approach used in a number of other
clinical reappraisal studies (Haro et al., 2006; Kessler et al., 2005b; Kessler et al., 1998), we
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modified the conventional blinded clinical re-interview design in three important ways to
address this problem.
First, we unblinded the clinical interviewers to whether respondents endorsed diagnostic
stem questions in the CIDI-SC. Importantly, though, we did not unblind clinical interviewers
to whether the respondents who endorsed CIDI-SC diagnostic stem questions went on to
meet full diagnostic criteria.
Second, we rephrased entry questions in the clinical reappraisal interviews to acknowledge
prior endorsement of diagnostic stem questions in the CIDI-SC/PCL in order to minimize
the problem of false negative diagnostic stem responses in the SCID. For example, rather
than repeating a question about presence-absence of 30-day depressed mood in the SCID to
respondents who reported 30-day depressed mood in the CIDI-SC, SCID interviews began
the assessment of major depression with a declarative sentence: “In your earlier survey you
reported feeling sad or depressed most of the time over the past 30 days. The next questions
ask more about those feelings.”
Third, in order to guarantee that this partial unblinding did not bias clinical interviewers in
the direction of rating all stem-positive respondents as cases, we enriched the clinical
reappraisal sample to include a higher proportion of respondents than in the sample who
endorsed CIDI-SC/PCL diagnostic stem questions but did not meet full CIDI-SC/PCL
diagnostic criteria. This third feature of the design actually makes the interviewer task more
difficult than it would be in a standard clinical reappraisal study in which there is an over-
sample of respondents classified as meeting full diagnostic criteria but not of respondents
meeting partial criteria.
Clinical interviewer training and quality control
The SCID interviews were administered by 14 trained clinical interviewers. These included
four doctoral-level psychologists, seven MA-level psychologists, and three MSW-level
clinical social workers. Half of the interviewers had a decade or more of clinical experiences
(10–21 years), while the other half had 3–9 years of clinical experience (two with 3 years of
experience and one each with 5, 6, 7, 8, and 9 years of experience). The 32-hour SCID
interviewer training program began with a 16-hour centralized group training session taking
place over a full weekend that was taught by one of the developers of the SCID (MBF) with
the assistance of an experienced SCID supervisor (CLD). Training then continued with
biweekly individual and group training sessions with homework assignments totaling 32
hours. The training was carried out at USUHS using a modification of the standard SCID
training protocol tailored to the diagnoses assessed by the screening scales. In addition to
completing this training, each clinical interviewer was required to pass a proficiency test
before they began production interviewing based on trainer and supervisor ratings of three
practice interviews using a modified version of the SCID Interviewing Skills Evaluation
Form created specifically for this study.
All SCID interviews were audio-recorded with permission of respondents and responses
recorded on a hard copy interview. The supervisor reviewed the tape recordings of the first
five interviews carried out by each interviewer and a minimum of 10% of all subsequent
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interviews carried out by each interviewer. The supervisor also reviewed all hard copy
interviews completed by all interviewers and reviewed tape recordings of all interviews in
which concerns were raised by the hard copy reviews. The symptom-level hard-copy clinical
ratings were double-entered into a computerized data file after supervisor review and
approval. Each interviewer had a weekly one-on-one feedback meeting with the supervisor
and participated in a biweekly group calibration meeting with the supervisor and trainer to
prevent rater drift. Diagnoses were made without diagnostic hierarchy rules but with organic
exclusions.
Analysis methods
Weighting—The CRS sample was weighted to adjust for over-sampling respondents
screened as threshold or subthreshold using a weighting method that adjusted for the fact
that sampling was made with replacement. This is important because a number of the
statistics used to describe scale characteristics are biased when differential selection of
screened positives and negatives is not taken into account.
Analysis of screening scale operating characteristics—As noted above in the
description of screening scale scoring, a summary continuous screening scale score was
created for each diagnosis by summing scores across the screening scale items. Receiver
operating characteristic curve (ROC) analysis (Margolis et al., 2002) was then used to
estimate area under the ROC curve (AUC) for the entire scale. Each continuous screening
scale was then dichotomized at a threshold that equalized the (weighted) number of false
positives and false negatives, thereby maximizing concordance between prevalence
estimates based on the SCID and the screening scales. The McNemar χ2 test was used to
evaluate the significance of differences between screening scale and SCID prevalence
estimates at this threshold. A range of other thresholds was then selected so that SCID
prevalence estimates increased monotonically across screening scale strata but did not differ
significantly within strata using the logic of stratum-specific likelihood ratio analysis (Pepe,
2003).
Screening scale operating characteristics were then evaluated for each of these thresholds.
Individual-level concordance was evaluated using AUC and Cohen’s κ (Cohen, 1960).
Although κ is the traditional measure used in psychiatric research, κ is not emphasized here
because it varies across populations that differ in prevalence even when sensitivity (SN; the
percent of true cases correctly classified) and specificity (SP; the percent of true non-cases
correctly classified) are constant (Cook, 1998). AUC, in comparison, is a function of SN and
SP, which are considered the fundamental parameters of agreement (Kraemer, 1992). AUC
equals (SN + SP)/2 when the screen is dichotomous. AUC scores between 0.5 and 1.0 are
often interpreted in parallel with κ as slight (AUC = .50–.59; κ = 0.0–.19), fair (AUC = .6–.
69; κ = .2–.39), moderate (AUC = .7–.79; κ = .4–.59), substantial (AUC = .8–.89; κ = .6–.
79), and almost perfect (AUC = .9+; κ = .8+) (Landis and Koch, 1977). We also report total
classification accuracy (TCA), the proportion of all respondents whose CIDI-SC and SCID
classifications are consistent.
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In addition, we report disaggregated measures of operating characteristics, including SN and
SP, positive predictive value (PPV; the proportion of screened positives confirmed by the
SCID), negative predictive value (NPV; the proportion of screened negatives confirmed as
non-cases by the SCID), likelihood ratio positive (LR+; [SN/(100-SP)]), and likelihood ratio
negative (LR−; [(100-SN)/SP)]). LR+ and LR− assess relative proportions of screened
positives vs. screened negatives confirmed as cases (LR+) or non-cases (LR−). LR+ values
greater than or equal to 5 and LR− values less than or equal to 0.2 are generally considered
useful, while LR+ values greater than or equal to 10 and LR− values less than or equal to 0.1
are considered sufficient to rule in/out diagnoses (Haynes et al., 2006). Significance tests
were based on Taylor series design-based standard errors to adjust for data weighting
(Wolter, 1985).
Multiple imputation of predicted probabilities of DSM-IV/SCID diagnoses—As
noted above in the subsection on scoring the screening scales, each screening scale was
originally scored continuously and then dichotomized. However, it is not necessary to
dichotomize screening scales to make them useful. This is true even in clinical applications,
where simple dichotomous scoring rules can be refined by using polychotomous rules that
collapse screening scale scores into strata based on analysis of data in a clinical reappraisal
study such that the observed prevalence of the clinical outcome differs significantly across
strata but not within strata (Guyatt and Rennie, 2001). Designations of patients into multiple
risk strata can be useful for clinical purposes when no sharp distinction between cases and
non-cases exists in the screening scale (e.g., borderline hypertension).
An extension of this approach can be used in epidemiological surveys to classify
respondents into multiple risk strata based on screening scale scores and to assign predicted
probabilities of clinical diagnoses to respondents in each stratum based on the results of a
clinical reappraisal survey. It is also possible to ignore the construction of strata in this
approach when a monotonic association exists throughout the scale range between a
screening scale and probability of a diagnosis, in which case regression analysis can be used
to generate predicted probabilities of clinical diagnoses for each respondent in a large
sample based on regression coefficients estimated in a smaller clinical reappraisal
subsample. These predicted probabilities can then be used either as continuous variables or
as the basis for making dichotomous distinctions using any of several different methods
discussed elsewhere (Kessler et al., 2010b; Kessler and Pennell, in press).
The creation of continuous scores of this sort is only useful, though, when significant
monotonic associations exist between screening scale scores and probabilities of having the
clinical diagnosis. We demonstrate below that such associations exist between screening
scale scores and diagnoses based on the SCID in the Army STARRS data by comparing
AUC for the continuous versions of the screening scales with AUC based on various
dichotomous versions of the scales. Given that these monotonic associations exist, we used
the method of multiple imputation (MI) (Rubin, 1987) to assign predicted probabilities of
SCID diagnoses based on screening scale scores to all respondents in the Army STARRS
surveys. MI is a two-phase method designed to impute missing values of particular variables
to respondents who have information on variables strongly related to the variable(s) with
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missing values in such a way as to maximize the use of all available data in examining
multivariate associations.
The first phase of MI develops prediction equations based on any of several different
complex search methods (Schafer, 2003; White et al., 2011) to estimate multivariate
associations of predictors with the variables to be imputed in the subset of respondents with
complete data and to use those equations to generate predicted values (imputations) for the
missing variables in the remainder of the sample. In order to address the fact that imputed
values are less precise than observed values, this first phase uses pseudo-replication (i.e.,
estimation of a new set of coefficients based on the same model from pseudo-samples
selected with replacement from the actual sample of people with complete data) to generate
multiple imputations for each missing value. The second phase of MI, in which the multiple
imputations are used in substantive analysis, then uses each set of imputed values to carry
out the substantive analysis separately and then combines the coefficient values across these
replications to adjust standard errors of estimates for the fact that some of the data used in
the analyses were imputed rather than observed.
Importantly, the first phase of MI allows the inclusion not only of a screening scale (in this
case, the CIDI-SC or PCL) designed to provide a proxy measure for the unmeasured
variable of interest (in this case, DSM-IV/SCID diagnoses), but also other variables that
might be used in second-phase analyses as predictors or consequences of the imputed
variable. This is important because the use of only the CIDI-SC or PCL to impute clinical
diagnoses would lead to under-estimation of the associations of predictors and consequences
of clinical diagnoses with the components of the clinical diagnoses that are not predicted by
the CIDI-SC or PCL scores (Collins et al., 2001). As a result, the multiply-imputed
predicted probabilities of DSM-IV/SCID diagnoses in Army STARRS were based on
complex multivariate equations that included the complete set of CIDI-SC/PCL scores to
impute each clinical diagnosis (to adjust for comorbidities among clinical disorders) along
with a wide range of substantive correlates included in the AAS and Army/DoD
administrative data systems. We produced 20 imputations for each respondent in Army
STARRS, a number at the high end of the number recommended in applying MI (Graham et
al., 2007).
RESULTS
Concordance of screening scale scores with DSM-IV/ SCID diagnoses
Differences in prevalence estimates based on the dichotomized screening scales and SCID
are insignificant for all disorders at optimal screening scale thresholds for estimating
prevalence (χ21 = 0.0–0.6, p = .89−.43). (Table 1) This is not surprising, of course, as the
thresholds were selected to make CIDI-SC prevalence as similar as possible to SCID
prevalence. But this is no guarantee of good concordance at the individual level. Individual-
level diagnostic concordance at these thresholds is moderate for seven diagnoses (AUC = .
70–79) and fair for the other diagnosis (ADHD; AUC = .69). Total classification accuracy is
in the range 86.0–95.9%. The screening scale estimate of 30-day prevalence of any of the
seven disorders assessed for 30-day prevalence (the exception being mania/hypomania,
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which was only assessed over the entire lifetime), like most of the individual disorders, has
moderate concordance with the estimate based on the SCID (AUC = .78).
Operating characteristics of the tests
The proportions of SCID cases detected (SN) at the optimal screening scale diagnostic
thresholds for estimating SCID prevalence are in the range 42.8–66.8% and the proportions
of screening scale cases confirmed by the SCID (PPV) at these thresholds are in the range
37.1–65.3% (68.3% for any 30-day disorder). (Table 2) The proportions of SCID non-cases
classified correctly (SP) are 90.9–97.8% and the proportions of screening scale non-cases
confirmed as non-cases by the SCID (NPV) are 91.5–97.8%. Lower SN and PPV than SP
and NPV are expected for thresholds designed to estimate prevalence without bias when
only a minority of respondents has a disorder. LR+ is generally considered more informative
than SN in such cases (Haynes et al., 2006). LR+ is in the definitive range (i.e., greater than
10.0) at these thresholds for six of the eight disorders and in the informative range (i.e.,
greater than 5.0) for the others (7.3 for IED; 7.8 for ADHD) and for any 30-day disorder
(8.5), indicating that screened positives at these thresholds are much more likely than
screened negatives to be confirmed as cases in the clinical reappraisal interviews. LR−
values, in comparison, are in a range that would not be considered useful in screening out
true non-cases (0.4–0.6).
The implications of modifying diagnostic thresholds
The proportions of screened positives confirmed as SCID cases (PPV) could be increased by
raising the screening scale diagnostic thresholds beyond the optimal for estimating
prevalence. However, this increase in PPV would be obtained at the expense of decreasing
SN and creating downwardly biased (conservative) prevalence estimates. The value of
making such a change in threshold while still attempting to approximate clinical prevalence
can be evaluated by examining relative changes in PPV vs. SN associated with modest
increases in screening scale thresholds around the optimal thresholds for estimating SCID
prevalence. When we make these small increases in threshold we see that the increases in
PPV are much less than the decreases in SN for four disorders (MDE, GAD, ADHD, SUD)
(proportional SC decreases of 20%, 7%, 25%, and 31%, respectively; proportional PPV
increases of 2%, 0%, 18%, and 4%, respectively). (Table 3) In addition, PPV actually
decreases slightly for the other four disorders due to respondents with CIDI-SC scores just
above the optimal thresholds for estimating SCID prevalence of these disorders having high
SCID prevalence. These results argue against small changes to increase the screening scale
thresholds in the service of making diagnoses more conservative while still maintaining
estimates that approximate the SCID prevalence estimates.
We also examined the implications of making small changes in the thresholds in the other
direction to increase the proportions of clinical cases screening positive by lowering the
screening scale thresholds. Such changes increase SN by definition. This is desirable for
purposes of guaranteeing comprehensive detection in treatment samples when PPV does not
decrease more than SN increases. However, such anticonservative changes can lead to
upward bias in prevalence estimates as well as to reductions in LR+ when the proportional
increases in SN are lower than the proportional decreases in SP. An analysis of these
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changes associated with modest decreases in screening scale thresholds shows that LR+
consistently decreases when modest changes are made to decrease thresholds. (Table 3)
These results argue against making the screening scale thresholds less conservative while
still maintaining estimates that approximate SCID prevalence.
Selecting alternative optimization rules in selecting screening scale diagnostic thresholds
As noted above in the section on analysis methods, the most useful thresholds for screening
scales differ depending on the uses to which the screening scales are put. As Army STARRS
is an epidemiological study rather than a clinical study, we place a premium on accurate
estimation of SCID prevalence. But in a clinical study, where screening scales might be used
for case-finding to select people for additional assessment and treatment, it might make
more sense to lower the threshold to capture as large a proportion of clinical cases as
feasible within the constraints of the cost-benefit ratio of screening and treatment. To
investigate the implications of using such a rule in setting screening scale thresholds, we
compared scale operating characteristics when the threshold was selected to detect 80% of
DSM-IV/SCID cases (i.e., SN = 80.0%).
This change leads to a lowering of screening scale thresholds for all disorders because SN is
consistently lower than 80% at the optimal threshold for estimating SCID prevalence. And
this, in turn, leads to substantial increases in screening scale prevalence (2.5–7.0 times the
prevalence estimates based on the optimal threshold for estimating SCID prevalence) for all
disorders other than PD and IED (where CIDI-SC prevalence estimates increase to 1.2–1.3
times the optimal for estimating SCID prevalence) and to correspondingly large reductions
in PPV. (Table 4) While PPV at the optimal threshold for estimating SCID prevalence
averages 51.6% (i.e., 51.6% of screened positives are true clinical cases, with a range of
37.1–65.3%), average PPV drops to 30.0% (range: 11.9–56.0%) when thresholds are
selected so that SN exceed 80%. This means that it would require an average of about three
SCID interviews to detect each clinical case among the screened positives at the lower
threshold compared to roughly two at the higher threshold. Clinical intervention cost-
effectiveness calculations would be needed to determine whether this additional expense of
case-finding could be justified based on the human costs (i.e., quality of life, morbidity,
mortality) of an untreated case, the costs of treatment, and the likely effectiveness of
treatment in reducing human costs. From the perspective of epidemiological research,
lowering the thresholds below the optimal for estimating prevalence might still be desirable
even though such an anticonservative change introduces upward bias in prevalence
estimates, as it is possible that lowering thresholds will lead to greater proportional increases
in SN than in (100-SP), in which case LR+ will increase. However, LR+ decreases
consistently when the screening scale thresholds are lowered, arguing against making these
thresholds less conservative for purposes of epidemiological analysis of the Army STARRS
data.
Another goal of screening might be to select screening scale thresholds to have a minimum
proportion of screened positives confirmed in clinical interviews (i.e., high PPV). For
example, minimum PPV might be set at 50% to guarantee that the majority of screened
positives are true clinical cases or at 80% to guarantee that the vast majority of screened
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positives are true clinical cases. However, this will lead to a reduction in SN that might
make the true cases detected unrepresentative of all true cases. If minimum PPV is set at
50%, the thresholds selected to maximize estimation of SCID prevalence meet the PPV
criterion in five of eight cases, the exceptions being MHM (PPV = 45.8%), GAD (PPV =
45.6%), and ADHD (PPV = 37.1%). In the case of MHM, the threshold can be raised to
increase PPV to 71.1%, but this leads to a dramatic reduction in estimated prevalence (from
4.9% to 0.7%) and in SN (from 43.5% to 9.7%). (Table 5) While more than two-thirds of the
small fraction of respondents defined as positive for MHM in the CIDI-SC are SCID cases,
the exclusion of the vast majority of SCID cases of MHM from this small fraction (100-SN
= 90.3% of SCID cases not detected) means that the proportion of SCID cases among the
screened negatives is nearly as high as the proportion among screened negatives (LR− =
0.9), arguing against making the screening scale thresholds this conservative for purposes of
epidemiological analysis of the Army STARRS data.
In the case of GAD, raising the CIDI-SC threshold to make PPV exceed 50% leads to
halving both estimated prevalence (from 6.6% to 3.2%) and SN (from 43.9% to 23.6%) in
the service of only a relatively modest increase in PPV (from 45.6% to 50.2%) compared to
when the threshold is set to maximize estimation of SCID prevalence. It is difficult to argue
for a threshold that decreases SN so dramatically for such a modest increase in PPV. The
situation is similar but less dramatic for ADHD, where a change in the CIDI-SC threshold
that increased PPV by roughly 50% (from 37.1% to 55.9%) decreased estimated prevalence
by 70% (from 8.2% to 2.4%) and SN by 55% (from 42.8% to 19.3%). Selecting thresholds
to have even higher PPV (a minimum of 80%) for disorders where screening scale PPV is
greater than 50% at the optimal threshold for estimating SCID prevalence consistently has
the same negative effects in that the proportional increases in PPV (in the range 47–59%)
are much less than the proportional decreases in prevalence (84–91%), resulting in
extremely low levels of SN (7.3–13.4%). These results argue against using such restrictive
thresholds for purposes of epidemiological analysis of the Army STARRS data.
Continuous versus dichotomous diagnostic classification
As noted above in the section on analysis methods, we calculated ROC curves for the entire
screening scale distributions. (Figure 1) AUC was calculated for each of these curves and
compared to the AUC of the dichotomous version of the same screening scale. AUC was
found to be substantially higher for the continuous than dichotomous scoring rule for each of
the eight screening scales (Range: .80–.90 continuous versus .69–.79 dichotomous; Inter-
quartile range: .85–.87 continuous versus .70–.78 dichotomous). (Table 6) This suggests that
meaningful variation in SCID prevalence exists at other places on the screening scale ranges
than the optimal diagnostic threshold for estimating SCID prevalence. The important
implication of this finding for our purposes is that continuous screening scale scores
defining predicted probabilities of clinical diagnoses might be more useful than dichotomous
diagnostic classifications based on the screening scales for purposes of epidemiological
analysis. We consequently calculated both continuous (predicted probability of having a
DSM-IV/SCID diagnosis) and dichotomous versions of each screening scale for use in
analysis of the Army STARRS data. The continuous versions were produced using the MI
method. Importantly, not only the screening scale scores but also a wide range of other
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significant correlates of the DSM-IV/SCID diagnoses were used in the first-phase MI
analysis in order to minimize bias in subsequent substantive analyses that will use these
variables as correlates of predicted probabilities of DSM-IV/SCID disorders.
DISCUSSION
Previous research has shown that CIDI-SC operating characteristics are equivalent to or
better than those of alternative screening scales in samples of the general population
(Kessler et al., 2005a; Kessler et al., 2006a; Kessler et al., 2012) and that the PCL has very
good concordance with clinical diagnoses of PTSD in samples of both the military and the
general population (Wilkins et al., 2011) We nonetheless carried out an independent clinical
reappraisal study of these screening scales in Army STARRS due to the fact that the
operating characteristics of the same screening scale can differ substantially across surveys
depending on such fundamental survey conditions as auspices, level of confidentiality (e.g.,
complete anonymity versus deidentification), mode of data collection, and situational
factors, such as constraint on the amount of time available to complete the survey (Kessler
and Pennell, in press).
It is not surprising in light of the challenging survey conditions in Army STARRS --
including group-administration in settings with suboptimal physical facilities (e.g., sitting on
folding chairs in full field gear in temporary data collection locations) -- that we found that
the CIDI-SC and PCL AUCs are somewhat lower than in previous psychometric studies of
these scales. Individual-level concordance of diagnoses based on the CIDI-SC and PCL with
diagnoses based on independent SCID clinical reappraisal interviews in the AAS is for most
part moderate (AUC = .70–.79; κ = .4–.6), whereas most previous evaluations found
concordance of the CIDI-SC scales and the PCL with SCID diagnoses to be substantial
(AUC = .80–.89; κ = .6–.8). However, the administrative conditions of the screening scales
in most previous studies that carried out clinical reappraisals were much better than in Army
STARRS, including self-administration in primary care waiting rooms (Kessler et al., 2012),
face-to-face interviewer administration in household surveys (Kessler et al., 2006a), and
interviewer administration over the telephone with health plan subscribers (Kessler et al.,
2005a).
Perhaps the more striking result in light of the challenging Army STARRS field conditions
is that the positive CIDI-SC/PCL operating characteristics for dichotomous versions of the
scales designed to optimize aggregate concordance with SCID prevalence estimates are
generally quite good. LR+ values for six of the eight disorders are in the range 11.5–27.9, all
of which are well above the 10.0 value generally considered sufficient to rule in diagnoses
(Haynes et al., 2006), while the 7.3–7.8 LR+ values for the other two diagnoses and the 8.5
LR+ value for any 30-day disorder are well above the 5.0 value considered useful in ruling
in diagnoses. However, these good LR+ values are accompanied by LR− values generally
considered not to be useful in screening out true negatives (0.4–0.6); that is, to contain
proportions of true negative that are not strikingly different from the proportions found
among screened positives.
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As discussed in more detail elsewhere (Kessler et al., 2012), the definitions of screened
positives and screened negatives could be purified for clinical purposes by selecting
thresholds at the tails of the distributions that have operating characteristics deemed useful
for clinical purposes. For example, an upper threshold of a screening scale could be selected
to have a minimum PPV of 0.5 in order to make sure that at least 50% of screened positives
are SCID cases. As we saw, though, this desirable feature of that threshold would generally
mean that a substantial proportion of SCID cases are missed. Alternatively, the upper
threshold of a screening scale could be set at a minimum SN of .80 to make sure that the
vast majority of SCID cases are picked up by the screen, but this desirable feature of that
threshold would mean that only a small proportion of screened positives have SCID
diagnoses. In a similar way, a lower threshold of a screening could be purified by requiring
NPV to be, say, at least 1 – p/5, where p = SCID prevalence of the disorder, thereby
guaranteeing that the proportion of SCID cases among patients screening negative is no
more than 20% as high as the prevalence of the disorder in the sample, but this desirable
feature of that threshold might mean that a substantial proportion of true non-cases are
excluded from this ruled-out group.
It is also possible to select multiple thresholds at upper and lower tails both to maximize the
positives (i.e., definitive screen-ins and/or screen-outs) and minimize the negatives (i.e.,
minimizing the numbers of false positives and/or false negatives) and leave one or more
intermediate strata that define those with high-but-not-definitively-high scores, low-but-not-
definitively-low scores, and uninformative intermediate scores. We noted earlier that such
polychotomous scoring rules are fairly common in screening scales developed for clnical
practice (Guyatt and Rennie, 2001). Indeed, CIDI-SC polychotomous thresholds have been
developed for exactly this reason to facilitate the use of these scales in primary care
screening (Kessler et al., 2012).
However, a more useful approach for purposes of epidemiological analysis of the screening
scales considered here is likely to be retention of the entire screening scale range given that
AUCs of continuous versions of the screening scales are higher than AUCs of dichotomized
versions of the scales at their unbiased thresholds. Based on this observation, we are using
MI to assign predicted probabilities of DSM-IV/SCID diagnoses to all Army STARRS
respondents who completed the screening scales. We are addressing the uncertainty of
inference from prediction equations using imputed rather than observed values by estimating
20 MI estimates of the predicted probability of having each clinical diagnosis for each
respondent. The practical use of this approach is illustrated in a more detailed
methodological exposition published previously in this journal (Kessler and Üstün, 2004) as
well as in a number of subsequent substantive reports that used this approach to estimate the
prevalence and correlates of several different DSM-IV/SCID disorders in other psychiatric
epidemiological studies (Fayyad et al., 2007; Huang et al., 2009; Kessler et al., 2005a).
However, second-phase of MI analysis can be computationally intensive even after the first-
phase multiple imputations, as each model has to be estimated 20 separate times rather than
once and the coefficients in these 20 replicates then need to be combined to calculate
adjusted standard errors. As a result, we also plan to work with dichotomously-scored
screening scale measures at the optimal diagnostic thresholds and to investigate the extent to
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which substantive results differ depending on whether this dichotomous approach is used
instead of MI. Dichotomous screening scale scoring will be used in cases where results are
relatively insensitive to the more refined estimates using MI.
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Figure 1. ROC curves for the associations between continuous screening scales and DSM-IV/
SCID diagnoses (n=460)a
aROC = receiver operating characteristic; SN = sensitivity; SP = specificity; DSM-IV =
Diagnostic and Statistical Manuel of Mental Disorders, Fourth Edition; SCID = Structured
Clinical Interview for DSM-IV.
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Table 6
Comparison of area under the receiver operating characteristic curve (AUC) based on the dichotomous
versions of the CIDI-SC scales as the optimal thresholds for estimating DSM-IV/SCID prevalence and based
on the continuous versions of the CIDI-SC scales (n = 460) a
Area under the curve (AUC)
Dichotomous Continuous
I. Mood disorders
  Major depressive episode .78 .90
  Mania/hypomania .70 .86
II. Anxiety disorders
  Panic disorder .78 .90
  Generalized anxiety disorder .70 .87
  Post-traumatic stress disorder .75 .81
III. Externalizing disorders
  Adult attention deficit/hyperactivity disorder .69 .85
  Intermittent explosive disorder .79 .86
  Substance use disorder .73 .80
aAnalyses are based on weighted data to adjust for the over-sampling of respondents screening positive on the CIDI-SC scales.
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